CDKN1A and prostate cancer: Furthermore, treatment with a senescence inducer Dox could induce concomitant increased mRNA expressions of both HNF4α and p21 in LNCaP and PC-3 cells, suggesting a direct association between two factors in prostate cancer cells (Supplementary Fig. S7c).